IQVIA Holdings Inc
NYSE:IQV

Watchlist Manager
IQVIA Holdings Inc Logo
IQVIA Holdings Inc
NYSE:IQV
Watchlist
Price: 201.82 USD 2.14% Market Closed
Market Cap: 36.7B USD
Have any thoughts about
IQVIA Holdings Inc?
Write Note

Gross Margin
IQVIA Holdings Inc

35.2%
Current
35%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
35.2%
=
Gross Profit
5.4B
/
Revenue
15.3B

Gross Margin Across Competitors

Country US
Market Cap 36.7B USD
Gross Margin
35%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 196.3B USD
Gross Margin
41%
Country US
Market Cap 170.3B USD
Gross Margin
60%
Country KR
Market Cap 66.5T KRW
Gross Margin
50%
Country CH
Market Cap 37.6B CHF
Gross Margin
29%
Country US
Market Cap 38.5B USD
Gross Margin
55%
Country US
Market Cap 26.4B USD
Gross Margin
59%
Country US
Market Cap 23B USD
Gross Margin
35%
Country US
Market Cap 22.3B USD
Gross Margin
64%
Country US
Market Cap 22.2B USD
Gross Margin
60%
No Stocks Found

IQVIA Holdings Inc
Glance View

Market Cap
36.7B USD
Industry
Life Sciences Tools & Services

IQVIA Holdings Inc. stands at the crossroads of healthcare and technology, blending innovative data analytics with deep industry expertise to enhance the clinical development and commercialization of pharmaceuticals. Founded in 2016 from the merger of IMS Health and Quintiles, IQVIA has rapidly positioned itself as a leader within the life sciences sector. The company's core mission revolves around leveraging vast sources of healthcare data and advanced artificial intelligence to provide actionable insights, streamline drug development processes, and facilitate improved patient outcomes. With a global footprint extending across more than 100 countries, IQVIA serves a diverse clientele, including biopharmaceutical companies, healthcare providers, and government organizations, making it a pivotal player in the ever-evolving healthcare landscape. For investors, IQVIA represents a compelling opportunity that combines robust financial performance with strong market demand driven by the growing complexities of drug development and regulatory environments. As the healthcare sector increasingly turns to data-driven decision-making, IQVIA's extensive suite of services—including real-world evidence, market access solutions, and technology-enabled clinical trial services—positions it favorably in a market ripe for innovation. The company's commitment to research and development, coupled with strategic partnerships and acquisitions, fuels its long-term growth trajectory. Furthermore, IQVIA's resilience in navigating industry shifts, highlighted by its consistent revenue growth and healthy profit margins, reflects a business model that is not only scalable but also agile enough to adapt to the challenges and opportunities of modern medicine.

IQV Intrinsic Value
259.71 USD
Undervaluation 22%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
35.2%
=
Gross Profit
5.4B
/
Revenue
15.3B
What is the Gross Margin of IQVIA Holdings Inc?

Based on IQVIA Holdings Inc's most recent financial statements, the company has Gross Margin of 35.2%.